Business
China gives conditional approval to Sinovac’s COVID-19 vaccine – Global Times
China’s drug regulator has given approval for the conditional mass use of COVID-19 vaccine produced by Chinese pharmaceutical firm Sinovac Biotech, China’s second…
Sinovac photo: Li Hao/GT
Chinas drug regulator has given approval for the conditional mass use of COVID-19 vaccine produced by Chinese pharmaceutical firm Sinovac Biotech, Chinas second COVID-19 vaccine, after Sinopharms vaccine, to receive conditional approval. Sinovac Biotech announced on Saturday that CoronaVac, an inactivated vaccine candidate against COVID-19, received authorization from Chinas National Medical Products Administration for conditional mass use in China on Friday.
The conditional…
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News10 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred